Delivery Order SPE2DB20D3103-SPE2DB21FN1H2
- Not listed
- This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a prime vendor pharmacy contract supporting the DLA Troop Support Medical organization. The contract, valued at $5,276.70, is a delivery order under the company's Indefinite Delivery Contract (IDC) with the DLA worth up to $999,999,999.00. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical...
- This federal contract award, valued at $10,510.80, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under an Indefinite Delivery Contract (IDC) worth up to $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The...
- This federal contract award, valued at $10,137.49, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,458.36 delivery order is a firm fixed-price contract that provides a variety of pharmaceutical products and medical supplies, including specialty medications, generic drugs, vaccines, syringes, and other medical commodities. This award is a part of Amerisourcebergen's larger $999,999,999...
- This federal contract award is for a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $28,595.49, is for the provision of pharmaceutical products and medical supplies to support federal healthcare programs, including those within the military and veterans' healthcare systems. The contract is a firm fixed-price delivery order under an...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,532.82, is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies,...
- This federal contract award is for a prime vendor pharmaceutical contract between the Defense Logistics Agency (DLA) and Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $5,099.93 delivery order, which falls under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with the DLA Troop Support Medical, covers the delivery of a broad range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, to provide a prime vendor pharmaceutical supply service to the DLA's Troop Support Medical branch. The contract, valued at $9,573.84, is a delivery order awarded under an Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 that runs through November 2026. The IDC enables the DLA to efficiently procure a comprehensive range of...
- This federal contract award, valued at $10,223.30, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order that falls under a larger Indefinite Delivery Contract (IDC) worth $999,999,999, which serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military...
- This federal contract award, valued at $5,024.70, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for prime vendor pharmaceutical products and supplies, supporting the DLA Troop Support Medical division. Amerisourcebergen, a subsidiary of the parent company Cencora, Inc., holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB21FN1H2Delivery Order
This federal contract award, valued at $10,468.79, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a delivery order, is for the provision of prime vendor pharmaceutical products and medical supplies to support the DLA Troop Support Medical program. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen Drug Corp holds with the DLA, which serves as the primary vehicle for delivering a comprehensive range of essential pharmaceutical and medical commodities to military treatment facilities, veterans' healthcare programs, and other federal medical institutions worldwide. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.5k | 4/5/21 |